Informed consent
The process by which a patient voluntarily agrees to medical treatment or participation in a clinical trial after being fully informed of the risks, benefits, and alternatives.
Frequently Asked Questions
What is Informed consent?
The process by which a patient voluntarily agrees to medical treatment or participation in a clinical trial after being fully informed of the risks, benefits, and alternatives.
Why is Informed consent important in peptide research?
Understanding informed consent is crucial for navigating the legal and regulatory landscape of peptide use. Regulatory knowledge helps practitioners and patients distinguish between approved therapies, compounded medications, and research chemicals.
Related Terms
Clinical trial phases
The staged process of testing a new drug in humans: Phase 1 (safety), Phase 2 (efficacy), Phase 3 (large-scale confirmation), and Phase 4 (post-marketing surveillance). Each phase has specific objectives and requirements.
IRB (institutional review board)An independent ethics committee that reviews and approves research involving human subjects. IRB approval is required before any clinical trial can begin, ensuring participant safety and ethical conduct.